WILMETTE, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today ...
Initial OnKure Therapeutics, Inc. data from PIKture-01 study on OKI-219 for PI3Ka-H1047R breast cancer expected in Q4, 2024.
Oxford University - Read all the latest news headline updates on Oxford University. Get all the Oxford University breaking news updates, videos, photostories and more at Business Standard.